International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY3 : 2024-05-29 |
|
International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY3 : 2024-05-29 ±³À°ÁÖÁ¦ : International Society for Molecular Neurodegeneration (ISMND) 2024 Conference ¹× 2024³â Á¦16ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ DAY3 ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ À̸ÞÀÏ : office@ismnd2024.org ±³À°Á¾·ù : ½Å°æ°ú Âü¼®¿¹»óÀÎ : 400¸í Áö¿ª : ¼¿ïƯº°½Ã ¼¼ºÎ¼ö°·á : 950,000¿ø ºñ°í ISMND ȸ¿ø - Professional: 600,000¿ø / Postdocs/Fellows/Residents: 300,000¿ø / Students: 100,000¿øISMND ºñȸ¿ø - Professional: 950,000¿ø / Postdocs/Fellows/Residents: 450,000¿ø / Students: 250,000¿ø
±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 08:30~08:45 Role of necroptosis in neuronal death and neurodegeneration Xiaodong Wang(National Institute of Biological Sciences) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 08:45~09:00 Role of TDP-43 splicing repression in Alzheimer's disease exhibiting co-pathology of TDP-43 Philip Wong(Johns Hopkins University) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:00~09:15 Aggregation/spreading of RNA binding proteins in ALS pathogenesis Sandrine Da Cruz(KU Leuven) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:15~09:30 Examining the therapeutic potential of microglial transplantation in chimeric models of AD and FTD Mathew Blurton-Jones(UC Irvine) Åä·Ð 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 09:30~09:50 Q&As () ÈÞ½Ä 05¿ù 29ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 09:50~10:10 Coffee Break / Exhibits () ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:10~10:25 Early events leading to neuronal dysfunction and neurodegeneration in glaucoma Adriana Di Polo(University of Montreal) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:25~10:40 The forefront of fight for vision: In vivo genome editing for retinal degeneration ±èÁ¤ÈÆ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:40~10:55 Ocular imaging and artificial intelligence-based approach to study eye diseases Carol Cheung(Chinese University of Hong Kong) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 10:55~11:10 Neuronal regulation of microglia homeostasis in development and disease Melanie Samuel(Baylor College of Medicine) Åä·Ð 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 11:10~11:30 Q&As () ½Ä»ç 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 12:00~13:00 Lunch Break () ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:00~13:20 Successes, challenges, and future directions in Alzheimer¡¯s disease ¹Ú±âÇü(°¡ÃµÀÇ´ë) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:20~13:40 Exploring lymphatic routes for brain clearance °í±Ô¿µ(Çѱ¹°úÇбâ¼ú¿ø) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 13:40~14:00 Can synaptic loss in Alzheimer ¼ºÀ翵(°í·ÁÀÇ´ë) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:00~14:20 Discovery of potent and selective Keap1/Nrf2 modulators for the treatment of Alzheimer¡¯s disease ¹Ú±â´ö(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø) ÈÞ½Ä 05¿ù 29ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 14:20~14:35 Coffee Break / Exhibits () ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:35~14:55 Crosstalk between neuroinflammation and synucleinopathy in Parkinson ±è¿µÀº(ÇѸ²ÀÇ´ë) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 14:55~15:15 Tau aggregation and novel treatment approaches in movement disorders ±èÀ±°æ(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 15:15~15:35 The role of mitochondrial genetics in the clinical management and therapeutic approaches of Parkinson's Disease Á¶¼º¾ç(¿ï»êÀÇ´ë) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 15:35~15:55 Role of Reactive Astrocytes on Neurodegeneration in ¥á-Synucleinopathy °¨ÅÂÀÎ(Çѱ¹°úÇбâ¼ú¿ø) ÈÞ½Ä 05¿ù 29ÀÏ ÄÁÆÛ·±½º·ë(³²) 4Ãþ ·Îºñ ¹× 402È£ 15:55~16:10 Coffee Break / Exhibits () ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 16:10~16:40 Lost in local translation: TDP-43 and FUS in axonal/neuromuscular junction maintenance and dysregulation in ALS Sandrine Da Cruz(KU Leuven) ±³À°½Ã°£ 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 16:40~17:10 TDP-43 dependent cryptic exon: functional fluid biomarker and target validation Philip Wong(Johns Hopkins University) Åä·Ð 05¿ù 29ÀÏ ¼¿ï ÄÚ¿¢½º ÄÁÆÛ·±½º·ë(³²) 4Ãþ 401È£ 17:10~17:30 Q&As ()
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|
Á¦¸ñ |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 894 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 686 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 656 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 775 , ´ñ±Û¼ö : 0 |
Ãßõ¼ö : 0 , Á¶È¸¼ö : 822 , ´ñ±Û¼ö : 0 |